当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:91.57亿  总市值:91.57亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,414,883,507.64669,167,2113,118,007,1022,506,428,102.71
  收到其他与经营活动有关的现金89,936,111.6371,577,160.24190,596,466.27103,796,244.88
  经营活动现金流入小计1,504,819,619.27740,744,371.243,308,603,568.272,610,224,347.59
  购买商品、接受劳务支付的现金303,416,496.29183,014,710.351,608,333,305.421,362,767,421.2
  支付给职工以及为职工支付的现金306,103,795.97146,741,402.57646,219,449.65500,063,667.36
  支付的各项税费121,141,337.0887,326,774.04459,288,521.45422,334,340.22
  支付其他与经营活动有关的现金424,535,605.51221,950,914.77902,242,428.98724,232,049.83
  经营活动现金流出小计1,155,197,234.85639,033,801.733,616,083,705.53,009,397,478.61
  经营活动产生的现金流量净额349,622,384.42101,710,569.51-307,480,137.23-399,173,131.02
二、投资活动产生的现金流量:
  收回投资收到的现金5,617,543,0111,554,983,0114,890,526,6093,400,000,000
  取得投资收益收到的现金19,865,775.2311,821,725.2334,471,884.0631,159,586.7
  处置固定资产、无形资产和其他长期资产收回的现金净额27,168-328,0421,110,995
  投资活动现金流入小计5,637,435,954.231,566,804,736.234,925,326,535.063,432,270,581.7
  购建固定资产、无形资产和其他长期资产支付的现金21,388,737.017,091,626.0992,789,129.3177,469,735.44
  投资支付的现金5,560,000,0001,760,000,0004,830,000,0003,100,000,000
  投资活动现金流出小计5,581,388,737.011,767,091,626.094,922,789,129.313,177,469,735.44
  投资活动产生的现金流量净额56,047,217.22-200,286,889.862,537,405.75254,800,846.26
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--22,093.47-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--22,093.47-
  偿还债务支付的现金--10,000,00010,000,000
  分配股利、利润或偿付利息支付的现金--925,830,458.58925,333,602.58
  其中:子公司支付给少数股东的股利、利润--40,631,072.240,631,072.2
  支付其他与筹资活动有关的现金2,268,340.771,635,144.826,698,042.217,466,326.51
  筹资活动现金流出小计2,268,340.771,635,144.82942,528,500.79942,799,929.09
  筹资活动产生的现金流量净额-2,268,340.77-1,635,144.82-942,506,407.32-942,799,929.09
四、汇率变动对现金及现金等价物的影响137,250.34-19,109.62-295,368.58-536,068.85
五、现金及现金等价物净增加额403,538,511.21-100,230,574.79-1,247,744,507.38-1,087,708,282.7
  加:期初现金及现金等价物余额1,037,960,698.511,037,960,698.512,285,705,205.892,285,705,205.89
  期末现金及现金等价物余额1,441,499,209.72937,730,123.721,037,960,698.511,197,996,923.19
补充资料:
  净利润81,569,934.45-502,731,508.3-
  资产减值准备7,523,637.63-62,809,452.67-
  固定资产和投资性房地产折旧71,317,619.15-147,403,484.51-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧71,317,619.15-147,403,484.51-
  无形资产摊销13,057,358.11-27,483,070.56-
  长期待摊费用摊销2,157,363-3,606,086.52-
  处置固定资产、无形资产和其他长期资产的损失653,722.6-240,150.99-
  固定资产报废损失--4,012,514.75-
  公允价值变动损失-5,812,389.88-12,985,379.3-
  财务费用794,028.38-3,510,443.37-
  投资损失-10,371,400.62--24,931,696.6-
  递延所得税-280,047.2-18,645,038.66-
  其中:递延所得税资产减少747,793.51-21,301,353.83-
    递延所得税负债增加-1,027,840.71--2,656,315.17-
  存货的减少119,542,113.73--25,487,853.21-
  经营性应收项目的减少246,443,621.92--415,024,535.63-
  经营性应付项目的增加-179,116,141.61--634,383,091.1-
  其他--2,769,762.08-
  现金的期末余额1,441,499,209.72-1,037,960,698.51-
  减:现金的期初余额1,037,960,698.51-2,285,705,205.89-
  现金及现金等价物的净增加额403,538,511.21--1,247,744,507.38-
公告日期2025-08-282025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑